perfluorocarbon
Small moleculeexperimental
Fluorocarbons are chemical compounds with carbon-fluorine bonds. Compounds that contain many C-F bonds often have distinctive properties, e.g., enhanced stability, volatility, and hydrophobicity. Several fluorocarbons and their derivatives are commercial polymers, refrigerants, drugs, and anesthetics. — Wikipedia
Clinical trial activity
4 trials · 7 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
4
Phase 3
0
Phase 4
0
Earliest trial started Sep 1, 2005 (NCT00174980)
Timeline
2000s
- Jan 1, 2005
Earliest Phase 2 Sponsor(trial)
Indications
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaFluorocarbon ↗
Also known as
- perfluorocarbon
- perfluorocarbon
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06850324 | Phase 2 | Jul 1, 2025 | University of Lausanne |
| NCT03463551 | Phase 2 | Sep 30, 2018 | Aurum Health Research Limited, University of Glasgow |
| NCT01391481 | Phase 2 | Aug 1, 2011 | Capital Medical University, People's Liberation Army of China |
| NCT00174980 | Phase 2 | Sep 1, 2005 | Tenax Therapeutics, Inc., Virginia Commonwealth University |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (7)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Aurum Health Research Limited | Academic/Hospital | 1 | 0 | 1 | 2018 |
| Capital Medical University | Academic/Hospital | 1 | 0 | 1 | 2011 |
| People's Liberation Army of China | Government | 1 | 1 | 1 | 2011 |
| Tenax Therapeutics, Inc. | For profit | 1 | 1 | 1 | 2005 |
| University of Glasgow | Academic/Hospital | 1 | 1 | 1 | 2018 |
| University of Lausanne | Academic/Hospital | 1 | 1 | 1 | 2025 |
| Virginia Commonwealth University | Academic/Hospital | 1 | 0 | 1 | 2005 |
7 organizations
Page 1 / 1